Ayr Wellness Inc. (OTCMKTS:AYRWF – Free Report) – Stock analysts at Ventum Cap Mkts issued their FY2024 EPS estimates for Ayr Wellness in a report released on Wednesday, November 13th. Ventum Cap Mkts analyst J. Zandberg forecasts that the company will post earnings per share of ($1.15) for the year. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Ventum Cap Mkts also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.22) EPS and FY2025 earnings at ($0.76) EPS.
Other equities research analysts also recently issued reports about the company. Atb Cap Markets downgraded Ayr Wellness from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 13th. Roth Capital raised Ayr Wellness to a “strong-buy” rating in a report on Friday, November 8th. Finally, Roth Mkm lowered their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a research report on Thursday.
Ayr Wellness Price Performance
OTCMKTS:AYRWF opened at $0.77 on Monday. The business’s 50-day simple moving average is $1.82 and its two-hundred day simple moving average is $1.98. Ayr Wellness has a 52 week low of $0.71 and a 52 week high of $4.09. The stock has a market cap of $87.90 million, a PE ratio of -0.35 and a beta of 2.00. The company has a quick ratio of 0.67, a current ratio of 1.59 and a debt-to-equity ratio of 0.76.
Ayr Wellness Company Profile
Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.
Featured Stories
- Five stocks we like better than Ayr Wellness
- Canadian Penny Stocks: Can They Make You Rich?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is the NASDAQ Stock Exchange?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Want to Profit on the Downtrend? Downtrends, Explained.
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.